STAT+: How Mayo Clinic’s patients are helping Merck train its AI

Mayo Clinic is collaborating with Merck to utilize its health data for training artificial intelligence (AI) systems. This partnership is part of a broader trend in healthcare that aims to integrate AI into medical practices, potentially enhancing diagnostic and treatment capabilities. The collaboration underscores the increasing importance of health data in developing AI technologies within the healthcare sector. In parallel, a provocative proposal has emerged suggesting that the FDA could allow a variety of AI devices to enter the market without undergoing the traditional pre-market review process. This proposal raises significant concerns regarding patient safety and regulatory oversight, as it could lead to the introduction of potentially risky AI devices without rigorous evaluation. The discussions surrounding this proposal reflect ongoing debates about the regulation of AI in healthcare, particularly the balance between fostering innovation and ensuring patient safety. An AI startup is advocating for certain AI-powered medical devices to be exempt from pre-market review by utilizing an obscure regulatory backdoor. This approach aims to expedite the introduction of AI technologies into the healthcare market, which could increase access to innovative solutions. However, the lack of thorough review processes may pose substantial risks associated with the deployment of these devices. Overall, the intersection of AI development and regulatory frameworks remains a critical area of focus as stakeholders navigate the complexities of bringing AI innovations to market while prioritizing patient safety. The ongoing discussions about FDA deregulation of AI devices highlight the evolving landscape of healthcare technology and the role of regulatory bodies in managing these advancements.